VANGUARD GROUP INC

Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

Symbol
CRNX on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned
9,311,600 shares
Security Ownership %
10%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX)

07 Apr 2025 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,311,600 shares of Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX). This represents 10% ownership of the company. In their previous filing dated 30 Jan 2025, VANGUARD GROUP INC had reported owning 9,089,391 shares, indicating an increase of +2.4%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.